Selective serotonin re-uptake inhibitors and the risk of bleeding

Expert Opinion on Drug Safety

Volumn 4, Issue 2, 2005, Pages 337-344

  Weinrieb, Robert M ^a   Auriacombe, Marc ^b   Lynch, Kevin G ^a   Lewis, James D ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITÉ DE BORDEAUX   (France)

Author keywords

Adverse events; Bleeding; Selective serotonin re uptake inhibitor (SSRI)

Indexed keywords

ACETYLSALICYLIC ACID; ALPHA2A INTERFERON; ALPHA2B INTERFERON; ANTIDEPRESSANT AGENT; ASCORBIC ACID; BENZATROPINE; CLOPIDOGREL; DESIPRAMINE; FLUOXETINE; FLUVOXAMINE; HALOPERIDOL; METHADONE; NONSTEROID ANTIINFLAMMATORY AGENT; NORTRIPTYLINE; PAROXETINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRICYCLIC ANTIDEPRESSANT AGENT; VENLAFAXINE; WARFARIN;

AGE; ANOREXIA; ANOREXIA NERVOSA; BLEEDING; BLEEDING TENDENCY; BRAIN HEMORRHAGE; CAUSE OF DEATH; CEREBROVASCULAR ACCIDENT; COMORBIDITY; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; DRUG SUBSTITUTION; ERYTHROCYTE TRANSFUSION; GASTROINTESTINAL HEMORRHAGE; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFORMATION RETRIEVAL; INTERMETHOD COMPARISON; MEDLINE; MENTAL DISEASE; METHODOLOGY; ORTHOPEDIC SURGERY; PANIC; PEPTIC ULCER; RETINA HEMORRHAGE; RETREATMENT; RETROSPECTIVE STUDY; REVIEW; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; RISK FACTOR; SKIN BRUISING; STROKE; SYSTEMATIC REVIEW; THROMBOCYTE AGGREGATION; THROMBOCYTOPENIA; TREATMENT WITHDRAWAL;

EID: 20944442466     PISSN: 14740338     EISSN: None     Source Type: Journal    
DOI: 10.1517/14740338.4.2.337     Document Type: Review

References (46)

1. GOLDBERG R: Selective Serotonin Reuptake Inhibitors: Infrequent Medical Adverse Effects. Arch. Fam. Med. (1998) 7:78-84.
2. MUSSELMAN D, LAWSON D, GUMNICK J et al.: Paroxetine for the Prevention of Depression Induced by High Dose Interferon Alfa. New Engl. J. Med. (2001) 344(13):961-966.
3. HAUSER P, KHOSLA J, AURORA H et al.: A Prospective Study of the incidence and open-label treatment of interferon-induced major depressive disorder in patients with hepatitis C. Mol Psychiatry (2002) 7(9):942-947.
4. HERGOVICH N, AIGNER M, EICHLER H et al.: Paroxetine decreases platelet serotonin storage and platelet function in human beings. Clinical Pharmacol. Ther. (2000) 68(4):435-441.
5. NAIR G, GURBEL P, O'CONNOR C et al.: Depression, Coronary Events, Platelet Inhibition, and Serotonin Reuptake Inhibitors. Am. J. Cardiol. (1999) 84(4):321-323.
6. WEINRIEB RM, AURIACOMBE M, LYNCH KG et al.: A Critical Review of Selective Serotonin Reuptake Inhibitor-Associated Bleeding: Balancing the Risk of Treating Hepatitis C-Infected Patients. J. Clin. Psychiatry (2003) 64(12):1502-1510.
7. VAN WALRAVEN C, MAMDANI M, WELLS P et al.: Inhibition of serotonin reuptake by antidepressants and upper gastrointestinal bleeding in elderly patients: retrospective cohort study. Br. Med. J. (2001) 323(7314):655-658.
8. BAK S, TSIROPOULOS I, KJAERSGAARD JO et al.: Selective Serotonin Reuptake Inhibitors and the Risk of Stroke: A Population Based Case-Control Study. Stroke (2002) 33(6):1465-1473.
9. DALTON SO, JOHANSEN C, MELLEMKJAER L et al.: Use of Selective Serotonin Reuptake Inhibitors and Risk of Upper Gastrointestinal Tract Bleeding: A Poulation-Based Cohort Study. Arch. Intern. Med. (2003) 163(1):59-64.
10. DE ABAJO FJ, RODRIGUEZ LAG, MONTERO D: Association between selective serotonin reuptake inhibitors and upper gastrointestinal bleeding: population based case-control study. Br. Med. J. (1999) 319(7217):I106-1109.
11. DE ABAJO F, JICK H, DERBY L et al.: Intracranial haemorrhage and use of selective serotonin reuptake inhibitors. Br. J. Clin. Pharmacol. (2000) 50(1):43-47.
12. LAYTON D, CLARK D, PEARCE G et al.: Is there an association between selective serotonin reuptake inhibitors and risk of abnormal bleeding? Results from a cohort study based on prescription event monitoring in England. Eur. J. Clin. Pharmacol. (2001) 57(2):167-76.
13. MOVIG KL, JANSSEN MW, DE WAAL MALEFIJT J et al.: Relationship of Serotonergic Antidepressants and Need for Blood Transfusion in Orthopedic Surgical Patients. Arch. Intern. Med. (2003) 163(19):2354-2358.
14. GARCIA-RODRIQUEZ L, JICK H: Risk of upper gastrointestinal bleeding and perforation associated with individual nonsteroidal anti-inflammatory drugs. Lancet (1994) 343:769-772.
15. CHRISTENSEN K, MCGUE M, YASHIN A et al.: Genetic and environmental infuluences on funtional abilitites among Danish twins agesd 75 years and older. J. Gerontology and Biological Science (2000) 55A:M446-M452.
16. GAIST D, BATHUM L, SKYTTHE A et al.: Strength and anthropometric measures in identical and fraternal twins: no evidence of masculinization of females with male co-twins. Epidemiology (2000) 11:340-343.
17. ARANTH J, LINDBERG C: Bleeding, a side effect of fluoxetine. Am. J. Psychiatry (1992) 149(3):412.
18. GUNZBERGER D, MARTINEZ D: Adverse vascular effects associated with fluoxetine. Am. J. Psychiatry (1992) 149(12):1751.
19. LAKE M, BIRMAHER B, WASSICK S et al.: Bleeding and Selective Serotonin Reuptake Inhibitors in Childhood and Adolescence. J. Child Adolesc. Psychopharmacol. (2000) 10(1):35-38.
20. NELVA A, GUY C, TARDY-PONCET B et al.: Syndromes hémorragiques sous antidépresseurs inhibiteurs sélectifs de la recapture de la sérotonine (ISRS). À propos de sept cas et revue de la littérature. Rev. Med. Interne (2000) 21:152-160.
21. OTTERVANGER J, STRICKER B, HULS J et al.: Bleeding Attributed to the Intake of Paroxetine. Am. J. Psychiatry (1994) 151(5):781-782.
22. VANDEL P, VANDEL S, KANTELIP J: SSRI-induced bleeding: two case reports. Therpie (2001) 56(4):445-447.
23. LINNEBUR SA, SASEEN JJ, PACE WD: Venlafaxine-Associated Vaginal Bleeding. Pharmacotherapy (2002) 22(5):652-655.
24. TIELENS J: Vitamin C for Paroxetine- and Fluvoxamine-Associated Bleeding. Am. J. Psychiatry (1997) 154(6):883-884.
25. RASKER M: Bloedingsrisico bij gebruik van fluoxetine of fluvoximine. Ned Tijdschr Geneesk (1993) 137:618.
26. ALDERMAN C, MORITZ C, BEN TOVIM D: Abnormal Platelet Aggregation Associated With Fluoxetine Therapy. Ann. Pharmacother. (1992) 26:1517-1519.
27. HUMPHRIES J, WHEBY M, VANDENBERG S: Fluoxetine and the Bleeding Time. Arch. Pathol. Lab. Med. (1990) 114:727-728.
28. DUIJVESTIJN YC, KALMEIJER MD, PASSIER AL et al.: Neonatal Intraventricular Haemorrhage Associated with Maternal Use of Paroxetine. J. Clin. Pharmacol. (2003) 56:581-582.
29. CALHOUN J, CALHOUN D: Prolonged Bleeding Time in a Patient Treated With Sertraline. Am. J. Psychiatry (1996) 153(3):443.
30. KOHN S, LABBATE L: Venlafaxine and ecchymosis. Can. J. Psychiatry (1997) 42(1):91.
31. LEUNG M, SHORE R: Fluvoxamine-associated bleeding. Can. J. Psychiatry (1996) 41(9):604-605.
32. WILMSHURST P, KUMAR A: Subhyaloid haemorrhage with fluoxetine. Eye (1996) 10(1):141.
33. PAI VB, KELLY MW: Bruising Associated with the Use of Fluoxetine. The Ann. Pharmacother. (1996) 30(JulyAugust):786-788.
34. COOPER T, VALCOUR V, GIBBONS R et al.: Spontaneous Ecchymoses due to Paroxetine Administration. Am. J. Med. (1998) 104(2):197-198.
35. DE MAISTRE E, ALLART C, LECOMPTE T et al.: Severe Bleeding Associated with use of Low Molecular Weight Heparin and Selective Serotonin Reuptake Inhibitors. The Am. J. Med. (2002) 113:530-532.
36. BASSOTTI G, SIETCHIPING F, DE ROBERTO G et al.: Symptomatic reversible duodenal compression due to iatrogenic retroperitoneal hematoma. Dig. Liver Dis. (2004) 36:78-81.
37. YARYURA-TOBIAS J, KIRSCHEN H NINAN P et al.: Fluoxetine and bleeding in obsessive-compulsive disorder. Am. J. Psychiatry (1992) 148(7):949.
38. SHEN W, SWARTZ C, CALHOUN J: Is inhibition of nitric oxide synthase a mechanism for SSRI-induced bleeding. Psychosomatics (1999) 40(3):268-269.
39. SMITH M, ROBINSON D: Sertraline and Vaginal Bleeding-A Possible Association. J. Am. Geriatr. Soc. (2002) 50(1):200-201.
40. EVANS TG, BUYS SS, RODGERS GM: Acquired abnormalities of platelet function. New Engl. J. Med. (1991) 324:1671.
41. SKOP B, BROWN T: Potential Vascular and Bleeding Complications of Treatment With Selective Serotonin Reuptake Inhibitors. Psychosomatics (1996) 37:12-16.
42. OYESANMI O, KUNKEL EJ, MONTI DA et al.: Hematological Side Effects of Psychotropics. Psychosomatics (1999) 40(5):414-421.
43. CELEDA P, DOLERA M, ALVAREZ E: Effects of acute and chronic treatment with fluvoxamine on extracellular and platelet serotonin in the blood of major depressive patients: relationship to clinical improvement. J. Affect. Disord. (1992) 25:243-249.
44. GILLMAN M, SANDYK R: Hematuria following tricyclic therapy. Am. J. Psychiatry (1984) 141(3):463-464.
45. RUBELL E: Does imipramine (Tofranil) cause oral bleeding? Pediatrics (1969) 43(1):144-1445.
46. LEWIS J, BILKER W, BRENSINGER C et al.: Hospitalization and Mortality Rates from Peptic Ulcer Disease and Gastrointestinal Bleeding in the 1990s: Relation to sales of NSAIDs and acid suppression medications. Am. J. Gastroenterol. (2002) 97(20):2540-2549.